HU

Hospital Universitario 12 de Octubre at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Universitario 12 de Octubre takes part in 14 sessions at ESMO 2026 in Madrid, its home city. Its program centres on small cell and non-small cell lung cancer, including HER2-mutant disease, and on advanced breast cancer, from ESR1-mutated to triple-negative disease. Other sessions cover long-term survival in mismatch repair-deficient endometrial cancer, bladder preservation, new drugs for refractory melanoma and digital pathology.

OrganizationESMO 2026 Attendance
HU
Hospital Universitario 12 de Octubre
Madrid, Spain
Cancer centre & hospital
Public university hospital of the Madrid regional health service, affiliated with Complutense University, in Madrid, Spain.
Chair
Fri Oct 23
13:30–15:00
SCLC: Can we finally tackle it?
with Hanyang University
Lung & thoracic cancers
Satellite
Fri Oct 23
18:15–19:45
Satellite
Fri Oct 23
18:15–18:20
Welcome and Introductions
Menarini Stemline - ESR1-mutated Advanced Breast Cancer: A Transforming Treatment Landscape
Breast cancerBiomarkers & precision oncology
Satellite
Fri Oct 23
18:20–18:45
Post-CDK4/6i Progression in ER+/HER2– mBC: The EU Landscape in 2026
Menarini Stemline - ESR1-mutated Advanced Breast Cancer: A Transforming Treatment Landscape
Breast cancerBiomarkers & precision oncology
Satellite
Fri Oct 23
18:35–18:50
Interpreting evidence for durable survival in dMMR/MSI-H EC
GSK - From evidence to clinical practice: Long-term survival outcomes in advanced endometrial cancer
Gynaecological cancers
Satellite
Fri Oct 23
19:00–19:40
A new eye on earlier stages in bladder cancer: Redefining bladder preservation in HR NMIBC
Johnson & Johnson - Personalizing GU Oncology Treatments: Maximizing Outcomes, Preserving Quality of Life · with Amsterdam UMC, San Raffaele Hospital
Genitourinary cancers
Satellite
Fri Oct 23
19:15–19:40
Mapping change: Evolving clinical practice and conversations
GSK - From evidence to clinical practice: Long-term survival outcomes in advanced endometrial cancer · with NYU Langone Perlmutter Cancer Center, Oncology Institute of Southern Switzerland (IOSI)
Gynaecological cancers
Satellite
Fri Oct 23
19:35–19:45
Summary and Closing
Menarini Stemline - ESR1-mutated Advanced Breast Cancer: A Transforming Treatment Landscape
Breast cancerBiomarkers & precision oncology
Talk
Sat Oct 24
15:30–15:45
Neuroendocrine tumors (NET)
Emerging therapies in endocrine and neuroendocrine neoplasms
Sarcoma, CNS, head & neck and rare cancers
Satellite
Sat Oct 24
18:35–18:55
HER2-mutant NSCLC: Transforming precision medicine into clinical reality
Boehringer Ingelheim International GmbH - HER2 and DLL3: Shaping the next generation of targeted cancer therapy
Lung & thoracic cancers
Satellite
Sat Oct 24
19:25–19:45
Establishing the present of clinical practice
PharmaMar - More time for patients: Reframing the course of ES-SCLC
Lung & thoracic cancers
Chair
Sun Oct 25
08:30–10:00
Rapid oral 2: NSCLC, metastatic
with Centre Léon Bérard, Gustave Roussy
Lung & thoracic cancers
Abstract
Sun Oct 25
08:40–08:52
Invited Discussant LBA76 and 2616RO
Rapid oral 2: NSCLC, metastatic
Lung & thoracic cancers
Abstract
Sun Oct 25
10:20–10:25
Abstract
Sun Oct 25
10:25–10:30
Chair
Sun Oct 25
14:45–16:15
Key challenges in managing patients with metastatic breast cancer
with Medical University of Vienna
Breast cancer
Chair
Sun Oct 25
15:00–16:00
YO Medical Students session: ESMO for medical students and young physicians
with Hospital Clínico Universitario de Valencia
Talk
Sun Oct 25
15:35–16:00
Turning the corner: Personalized therapy for triple-negative breast cancer becomes a reality
Key challenges in managing patients with metastatic breast cancer
Breast cancer
Satellite
Sun Oct 25
19:00–19:10
Digital pathology and AI: How do we implement them and show clinical impact?
MSD - Is the precision medicine ecosystem ready? Overcoming diagnostic barriers in oncology
Biomarkers & precision oncology
Talk
Mon Oct 26
08:30–08:50
Translating new ideas into trials
YO Forum: Thinking beyond traditional research ideas
Chair
Mon Oct 26
08:30–10:00
YO Forum: Thinking beyond traditional research ideas
with Sestre milosrdnice University Hospital Centre
Satellite
Mon Oct 26
13:00–14:30
Satellite
Mon Oct 26
13:00–13:05
Welcome and Introduction
Daiichi Sankyo and MSD - Shaping the Future of ES-SCLC: Pioneering Treatment Strategies
Lung & thoracic cancers
Satellite
Mon Oct 26
13:55–14:15
Improving Patient Outcomes: Lessons from Other Indications
Daiichi Sankyo and MSD - Shaping the Future of ES-SCLC: Pioneering Treatment Strategies
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Hospital Universitario 12 de Octubre

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction